CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 85 enrolled
Drug / intervention
suanzaoren decoction +1 moredrug
Likely dose
Eszopiclone 1 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06452953
NCT06452953N/ACompleted
CompareCT.gov

Comparative Study on the Cognitive Function and Brain Imaging of Modified Suanzaoren Decoction and Eszopiclone in the Treatment of Primary Insomnia Patients With Yin Deficiency and Hyperactivity of Fire Syndrome

Central South University·interventional·Posted Jun 11, 2024·Updated Jun 11, 2024

In Brief

A clinical study evaluating suanzaoren decoction and Eszopiclone 1 mg for Chronic Insomnia Disorder. Completed, enrolled 85 participants across 1 site.

Detailed Summary

The purpose of this study is to observe the cognitive function and clinical efficacy of modified Suanzaoren decoction and eszopiclone in the treatment of chronic insomnia disorder patients, and to investigate the possible neural mechanisms using MRI techniques.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Insomnia Disorder
CountriesChina
CollaboratorsThe Third Hospital of Inner Mongolia Autonomous Region

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJun 11, 2024
Enrollment StartSep 10, 2020
Primary CompletionOct 31, 2023
Study CompletionMar 1, 2024
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 2.1 years ago

Interventions

suanzaoren decoctiondrug

The Suanzaoren decoction is a Chinese herbal formula known for nourishing the blood, calming the mind, and nourishing the heart and liver

Eszopiclone 1 mgdrug

Eszopiclone is used in the treatment of various types of insomnia.